{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:25:25Z","timestamp":1784784325013,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","award":["33-2022"],"award-info":[{"award-number":["33-2022"]}],"id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jsps.2023.101710","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T12:47:54Z","timestamp":1690462074000},"page":"101710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan"],"prefix":"10.1007","volume":"31","author":[{"given":"Ahmad","family":"Al-Azayzih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan S.","family":"Jarab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas","family":"Bani-Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saja","family":"Smadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8012-684X","authenticated-orcid":false,"given":"Zelal","family":"Kharaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4260-1117","authenticated-orcid":false,"given":"Khalid A.","family":"Al-Kubaisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2023.101710_b0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1200\/GO.20.00044","article-title":"Trends, patterns, and treatment outcomes of cancer among older patients in Jordan: a retrospective analysis of national cancer registry and institutional outcome data","volume":"6","author":"Abdel-Razeq","year":"2020","journal-title":"JCO Glob. Oncol."},{"key":"10.1016\/j.jsps.2023.101710_b0010","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2147\/CIA.S365497","article-title":"Breast cancer in geriatric patients: current landscape and future prospects","volume":"17","author":"Abdel-Razeq","year":"2022","journal-title":"Clin. Interv. Aging"},{"issue":"4","key":"10.1016\/j.jsps.2023.101710_b0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jsps.2020.03.001","article-title":"Nonsteroidal anti-inflammatory drugs utilization patterns and risk of adverse events due to drug-drug interactions among elderly patients: a study from Jordan","volume":"28","author":"Al-Azayzih","year":"2020","journal-title":"Saudi Pharm. J."},{"issue":"6","key":"10.1016\/j.jsps.2023.101710_b0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/fcp.12560","article-title":"Are potentially inappropriate and anticholinergic medications being prescribed for institutionalized elderly subjects?","volume":"34","author":"Bourrel","year":"2020","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2023.101710_b0025","first-page":"225","article-title":"The cognitive impact of anticholinergics: a clinical review","volume":"4","author":"Campbell","year":"2009","journal-title":"Clin. Interv. Aging"},{"issue":"4","key":"10.1016\/j.jsps.2023.101710_b0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cger.2022.05.004","article-title":"Polypharmacy in older adults","volume":"38","author":"Canio","year":"2022","journal-title":"Clin. Geriatr. Med."},{"issue":"12","key":"10.1016\/j.jsps.2023.101710_b0035","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0091270006292126","article-title":"The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity","volume":"46","author":"Carnahan","year":"2006","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jsps.2023.101710_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-65989-9","article-title":"Anticholinergic burden in children, adults and older adults in Slovenia: A nationwide database study","volume":"10","author":"Cebron Lipovec","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jsps.2023.101710_b0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11597530-000000000-00000","article-title":"Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder","volume":"29","author":"Chancellor","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jsps.2023.101710_b0050","article-title":"Association of polypharmacy with all-cause mortality and adverse events among elderly colorectal cancer survivors","author":"Choi","year":"2023","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jsps.2023.101710_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40266-015-0332-3","article-title":"Potentially inappropriate medications and anticholinergic burden in older people attending memory clinics in Australia","volume":"33","author":"Cross","year":"2016","journal-title":"Drugs Aging"},{"issue":"12","key":"10.1016\/j.jsps.2023.101710_b0060","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1007\/s00520-021-06437-w","article-title":"MASCC antiemetics in advanced cancer updated guideline","volume":"29","author":"Davis","year":"2021","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.jsps.2023.101710_b0065","doi-asserted-by":"crossref","DOI":"10.1007\/s00228-013-1536-2","article-title":"Systematic review of anticholinergic risk scales in older adults. Response to letter of the editor","volume":"69","author":"Duran","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.jsps.2023.101710_b0070","first-page":"140","article-title":"Anticholinergic burden and most common anticholinergic-acting medicines in older general practice patients","volume":"57","author":"Gorup","year":"2018","journal-title":"Zdr. Varst."},{"issue":"1","key":"10.1016\/j.jsps.2023.101710_b0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1368-5031.2006.00768.x","volume":"60","author":"Hansen","year":"2006","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.jsps.2023.101710_b0080","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/pds.5590","article-title":"Is anticholinergic and sedative drug burden associated with postdischarge institutionalization in community-dwelling older patients acutely admitted to hospital? A Norwegian registry-based study","volume":"32","author":"Havnes","year":"2023","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"7","key":"10.1016\/j.jsps.2023.101710_b0085","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/ggi.13680","article-title":"Development of an Anticholinergic Burden Scale specific for Korean older adults","volume":"19","author":"Jun","year":"2019","journal-title":"Geriatr. Gerontol. Int."},{"issue":"1","key":"10.1016\/j.jsps.2023.101710_b0090","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-018-0929-6","article-title":"An anticholinergic burden score for German prescribers: score development","volume":"18","author":"Kiesel","year":"2018","journal-title":"BMC Geriatr."},{"issue":"3","key":"10.1016\/j.jsps.2023.101710_b0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/001316447003000308","article-title":"Determining sample size for research activities","volume":"30","author":"Krejcie","year":"1970","journal-title":"Educ. Psychol. Meas."},{"issue":"2","key":"10.1016\/j.jsps.2023.101710_b0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00228-020-02994-x","article-title":"Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review","volume":"77","author":"Lisibach","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2023.101710_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.01309","article-title":"Anticholinergic drugs in geriatric psychopharmacology","volume":"13","author":"Lopez-Alvarez","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.jsps.2023.101710_b0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jsps.2023.101710_b0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaneurol.2018.2820","article-title":"Patterns of dementia treatment and frank prescribing errors in older adults with Parkinson disease","volume":"76","author":"Mantri","year":"2019","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.jsps.2023.101710_b0120","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jagp.2017.01.009","article-title":"Comparison of nine instruments to calculate anticholinergic load in a large cohort of older outpatients: association with cognitive and functional decline, falls, and use of laxatives","volume":"25","author":"Mayer","year":"2017","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.jsps.2023.101710_b0125","first-page":"139","article-title":"The evaluation of relationship between polypharmacy and anticholinergic burden scales","volume":"8","author":"Okudur","year":"2021","journal-title":"North Clin. Istanb."},{"issue":"2","key":"10.1016\/j.jsps.2023.101710_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12020207","article-title":"CRIDECO anticholinergic load scale: an updated anticholinergic burden scale. comparison with the ACB scale in spanish individuals with subjective memory complaints","volume":"12","author":"Ramos","year":"2022","journal-title":"J. Pers. Med."},{"issue":"5","key":"10.1016\/j.jsps.2023.101710_b0135","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jsps.2023.101710_b0140","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-015-0029-9","article-title":"Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review","volume":"15","author":"Salahudeen","year":"2015","journal-title":"BMC Geriatr."},{"issue":"1","key":"10.1016\/j.jsps.2023.101710_b0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jgs.13206","article-title":"Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people","volume":"63","author":"Salahudeen","year":"2015","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.jsps.2023.101710_b0150","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-021-00954-w","article-title":"Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer's disease dementia","volume":"14","author":"Sultzer","year":"2022","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.jsps.2023.101710_b0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00520-015-2775-9","article-title":"Treatment complexity: a description of chemotherapy and supportive care treatment visits in patients with advanced-stage cancer diagnoses","volume":"24","author":"Sumpio","year":"2016","journal-title":"Support Care Cancer"},{"issue":"40","key":"10.1016\/j.jsps.2023.101710_b0160","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2174\/1381612827666210830164054","article-title":"Anticholinergic exposure in elderly complex chronic patients: a cross-sectional study","volume":"27","author":"Tristancho-Perez","year":"2021","journal-title":"Curr. Pharm. Des."},{"issue":"Suppl 21","key":"10.1016\/j.jsps.2023.101710_b0165","first-page":"11","article-title":"Anticholinergic effects of medication in elderly patients","volume":"62","author":"Tune","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"28","key":"10.1016\/j.jsps.2023.101710_b0170","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.2174\/1381612824666180327154239","article-title":"Association between drug burden index and functional and cognitive function in patients with multimorbidity","volume":"24","author":"Villalba-Moreno","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.jsps.2023.101710_b0175","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1331\/JAPhA.2013.12138","article-title":"Evaluation of anticholinergic burden of medications in older adults","volume":"53","author":"West","year":"2013","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.jsps.2023.101710_b0180","unstructured":"WHO. World Health Organization. Anatomical Therapeutic Chemical (ATC) classification system. Retrieved from https:\/\/www.who.int\/standards\/classifications\/other-classifications\/the-anatomical-therapeutic-chemical-classification-system-with-defined-daily-doses."},{"issue":"4","key":"10.1016\/j.jsps.2023.101710_b0185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jgo.2015.12.002","article-title":"Comorbidity in older adults with cancer","volume":"7","author":"Williams","year":"2016","journal-title":"J. Geriatr. Oncol."},{"issue":"2","key":"10.1016\/j.jsps.2023.101710_b0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/agm2.12250","article-title":"Polypharmacy and cumulative anticholinergic burden in older adults hospitalized with fall","volume":"6","author":"Wong","year":"2023","journal-title":"Aging Med. (Milton)"}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423002050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423002050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:28:29Z","timestamp":1736184509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016423002050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1319016423002050"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101710","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"101710"}}